Hepta AI Reports MRE-Level Accuracy in Identifying Patients for MASH Drugs
Hepta says its AI can read liver biology from a routine blood draw and identify patients for newly approved MASH drugs with accuracy comparable to MRE. The body is truncated.
Hepta says its AI can read liver biology from a routine blood draw and identify patients for newly approved MASH drugs with accuracy comparable to MRE. The body is truncated.